Clinical trial
Efficacy and Safety of Etanercept in Active Rheumatoid Arthritis Despite Methotrexate Therapy in Japan
NCT00688103 is registered in ClinicalTrials.gov with Japan Biological Agent Study Integrated Consortium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Etanercept in Active Rheumatoid Arthritis Despite Methotrexate Therapy in Japan
- Lead sponsor
- Japan Biological Agent Study Integrated Consortium
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2005
- Completion date
- October 31, 2010
- Enrollment
- 151 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis